leuprolide 3-month microsphere (IVL3008) / Inventage Lab - LARVOL DELTA

Development of novel long-acting leuprolide acetates and the studies for their physicochemical and pharmacokinetic/pharmacodynamic (PK/PD) properties (EACR 2024) - "The analysis taken together with PK/PD studies indicates that IVL-LEUPs showed improved safety profiles and less probability of initial overproduction of TT compared to references, presumably due to precise control over their drug-releasing capabilities. Based on the positive results, Phase I IND-enabling studies are ongoing."

PK/PD data • Oncology • AR